Zsuzsanna Schelz

Dr. Zsuzsanna Schelz

Institute of Pharmacodynamics and Biopharmacy, University of Szeged, Faculty of Pharmacy, Szeged, Csongrád, Hungary
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2006 in Fitoterapia
Verified
Journal Article
Closed access
Zsuzsanna SchelzZsuzsanna Schelz
Zsuzsanna Schelz
JMJoseph Molnar
Joseph Molnar
JHJudit Hohmann
Judit Hohmann

1 March 2008 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MMMarta Martins
Marta Martins
SDSujata G. Dastidar
Sujata G. Dastidar
SFSéamus Fanning
Séamus Fanning
JKJette E. Kristiansen
Jette E. Kristiansen
JMJoseph Molnar
Joseph Molnar
LALeonard Amaral
Leonard Amaral

13 October 2009 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
MSMira Ágnes Szabó
Mira Ágnes Szabó
GVGábor Zoltán Varga
Gábor Zoltán Varga
JHJudit Hohmann
Judit Hohmann
Zsuzsanna SchelzZsuzsanna Schelz
Zsuzsanna Schelz
ESErnő Szegedi
Ernő Szegedi
JMJózsef Molnár
József Molnár

1 July 2006 in Current Drug Targets
Verified
Journal Article
Closed access
PDF file
Gabriella SpenglerGabriella Spengler
Gabriella Spengler
AMAnnamaria Molnar
Annamaria Molnar
Zsuzsanna SchelzZsuzsanna Schelz
Zsuzsanna Schelz
LALeonard Amaral
Leonard Amaral
DSDerek Sharples
Derek Sharples
JMJoseph Molnar
Joseph Molnar
Bacterial plasmids have a major impact on metabolic function. Lactose fermentation of E. coli or hemolysin B transporter expressed by the plasmids that carry these respective genes could be readily obviated by heterocyclic compounds that readily bind to plasmid DNA. These compounds could also reverse the resistance to antibiotics of E. coli , Enterobacter, Proteus, Staphylococcus and Yersinia strains by eliminating plasmids. However, the frequency and extent of this effect was significantly less than might have been expected based on a complex interaction with plasmid DNA. The effects of heterocyclic compounds on the plasmids responsible for the virulence of Yersinia and A. tumefaciens, or on nodulation, nitrogen fixation of Rhizobia accounted for the elimination of 0.1 to 1.0 % of plasmids present in the populations studied. Bacterial plasmids can be eliminated from bacterial species grown as pure or mixed bacterial cultures in the presence of sub-inhibitory concentrations of non-mutagenic heterocyclic compounds. The antiplasmid action of the compounds depends on the chemical structure of amphiphillic compounds having a planar ring system with substitution in the L-molecular region. A symmetrical π-electron conjugation at the highest occupied molecular orbitals favours the antiplasmid effect. The antiplasmid effect of heterocyclic compounds is expressed differentially in accordance with the structural form of the DNA to which they bind. In this manner "extrachromosomal" plasmid DNA that exists in a superhelical state binds more compound than its linear or open-circular form; and least to the chromosomal DNA of the bacterium, that carries the plasmid. It can also be noted that these compounds are not mutagenic and their antiplasmid effects correlate with the energy of HOMO-orbitals. Plasmid elimination is considered also to take place in ecosystems containing numerous bacterial species. This opens up a new perspective in rational drug design against bacterial plasmids. The inhibition of conjugational transfer of antibiotic resistance plasmid can be exploited to reduce the spread of antibiotic resistance plasmid in the ecosystem. Inhibition of plasmid replication at various stages, as shown in the "rolling circle" model (replication, partition, conjugal transfer) may also be the theoretical basis for the elimination of bacterial virulence in the case of plasmid mediated pathogenicity and antibiotic resistance. The large number of compounds tested for antiplasmid effects provides opportunities for QSAR studies in order to find a correlation between the antiplasmid effect and the supramolecular chemistry of these plasmid curing compounds. Plasmid elimination in vitro provides a method of isolating plasmid free bacteria for biotechnology without any risk of inducing mutations.

27 May 2022 in Plants
Verified
Journal Article
Open access
PDF file
TGTasneem Sultan Abu Ghazal
Tasneem Sultan Abu Ghazal
Zsuzsanna SchelzZsuzsanna Schelz
Zsuzsanna Schelz
LVLívia Vidács
Lívia Vidács
NSNikoletta Szemerédi
Nikoletta Szemerédi
KVKatalin Veres
Katalin Veres
JHJudit Hohmann
Judit Hohmann
Origanum majorana L. is a widely used medicinal plant; its distilled oil and preparations are extensively utilised in the phytotherapy and food industries. The objective of this study is to evaluate the extracts and the essential oil (EO) of Origanum majorana L, and its monoterpenes for antimicrobial, bacterial multidrug resistance reversing, and biofilm formation inhibitory potency. The composition of EO and n-hexane extract was characterized by GC-MS. In the essential oil terpinen-4-ol (24.92%), trans-sabinene hydrate (25.18%), γ-terpinene (6.48%), cis-sabinene hydrate (5.44%), p-cymene (4.72%), sabinene (4.53%), α-terpineol (4.43%), and α-terpinene (3.00%) were found as the main constituents while trans-sabinene hydrate (1.43%), and terpinen-4-ol (0.19%) were detected in the n-hexane extract besides a series of hydrocarbons. The antibacterial activity of EO and terpinen-4-ol, α-terpinene, and linalool was also assessed against sensitive and drug-resistant S. aureus, and E. coli strains with MIC values of 0.125–0.250% and 30–61 µM, respectively. In the efflux pump (EP) inhibitory assay, made by the ethidium bromide accumulation method in E. coli ATCC 25922, and AG100 and S. aureus ATCC 25923, and MRSA ATCC 43300 strains, EO exhibited substantial activity, especially in the E. coli ATCC 25922 strain. Among the EO constituents, only sabinene was an EP inhibitor in sensitive Escherichia strain. In the case of S. aureus strains, EO and sabinene hydrate exhibited moderate potency on the drug-resistant phenotype. The antibiofilm effects of the samples were tested by crystal violet staining at sub-MIC concentration. γ-Terpinene, terpinen-4-ol, sabinene, sabinene hydrate and linalool were found to be effective inhibitors of biofilm formation (inhibition 36–86%) on E. coli ATCC 25922 and S. aureus MRSA ATCC 43300, while EO was ineffective on these strains. In contrast to this, biofilms formed by E. coli AG100 and S. aureus ATCC 25923 were significantly inhibited by the EO; however, it was not affected by any of the monoterpenes. This observation suggests that the antibiofilm effect might be altered by the synergism between the components of the essential oil.

1 March 2007 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
MMMarta Martins
Marta Martins
Zsuzsanna SchelzZsuzsanna Schelz
Zsuzsanna Schelz
AMAna Martins
Ana Martins
JMJoseph Molnar
Joseph Molnar
GHGyorgy Hajös
Gyorgy Hajös
LALeonard Amaral
Leonard Amaral